SCHEMBL16761024

SCHEMBL16761024

CCOP(=O)(OCC)C(F)C(=O)OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
GAA P10253 3/20 0.38
POLB P06746 1/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
TSHR P16473 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
MAPT P10636 3/20 0.35
RAB9A P51151 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL365852 0.86 CYP3A4 (0.39) CYP3A4CYP2C9CYP2C19GAAPOLB
SCHEMBL17249688 0.81 ALDH1A1 (0.39) CYP3A4CYP2C9CYP2C19GAAPOLB
SCHEMBL16979607 0.79 CYP3A4 (0.38) CYP3A4CYP2C9CYP2C19GAAPOLB
SCHEMBL2992966 0.79 CYP3A4 (0.40) CYP3A4CYP2C9CYP2C19GAAPOLB
SCHEMBL2646513 0.79 POLB (0.43) CYP3A4CYP2C9CYP2C19GAAPOLB
SCHEMBL2984783 0.79 SMN1; SMN2 (0.37) CYP2C19CA12CA1CA2CA9
SCHEMBL18532983 0.78 GAA (0.41) CYP3A4CYP2C9CYP2C19GAAPOLB
SCHEMBL16978355 0.78 CYP3A4 (0.34) CYP3A4CYP2C9CYP2C19GAAPOLB
SCHEMBL9617315 0.78 LMNA (0.39) CYP3A4CYP2C9CYP2C19GAAPOLB
SCHEMBL14671697 0.78 CYP3A4 (0.42) CYP3A4CYP2C9CYP2C19GAAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180198166-A1 NON-AQUEOUS ELECTROLYTE AND POWER STORAGE DEVICE USING SAME UBE INDUSTRIES, LTD. (JP) 2018-07-12 US claimed
US-9966632-B2 Non-aqueous electrolyte and power storage device using same UBE INDUSTRIES, LTD. (JP) 2018-05-08 US claimed
EP-2882030-B1 NON-AQUEOUS ELECTROLYTE AND ENERGY STORAGE DEVICE USING THE SAME UBE INDUSTRIES (JP) 2017-06-21 EP claimed
US-20150221985-A1 NON-AQUEOUS ELECTROLYTE AND POWER STORAGE DEVICE USING SAME UBE INDUSTRIES, LTD. (JP) 2015-08-06 US claimed
EP-2882030-A1 NON-AQUEOUS ELECTROLYTE AND POWER STORAGE DEVICE USING SAME Ube Industries, Ltd. (JP) 2015-06-10 EP claimed
US-11396512-B2 CDK2/4/6 inhibitors PFIZER INC. (US) 2022-07-26 US disclosed
US-20200392142-A1 CDK2/4/6 Inhibitors PFIZER INC. (US) 2020-12-17 US disclosed
US-20180198166-A1 NON-AQUEOUS ELECTROLYTE AND POWER STORAGE DEVICE USING SAME UBE INDUSTRIES, LTD. (JP) 2018-07-12 US disclosed
US-20180198166-A1 NON-AQUEOUS ELECTROLYTE AND POWER STORAGE DEVICE USING SAME UBE INDUSTRIES, LTD. (JP) 2018-07-12 US disclosed
US-20180198166-A1 NON-AQUEOUS ELECTROLYTE AND POWER STORAGE DEVICE USING SAME UBE INDUSTRIES, LTD. (JP) 2018-07-12 US disclosed
US-9966632-B2 Non-aqueous electrolyte and power storage device using same UBE INDUSTRIES, LTD. (JP) 2018-05-08 US disclosed
US-9966632-B2 Non-aqueous electrolyte and power storage device using same UBE INDUSTRIES, LTD. (JP) 2018-05-08 US disclosed
US-20150333370-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTRICITY STORAGE DEVICE USING SAME UBE INDUSTRIES, LTD. (JP) 2015-11-19 US disclosed
US-20150333370-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTRICITY STORAGE DEVICE USING SAME UBE INDUSTRIES, LTD. (JP) 2015-11-19 US disclosed
US-20150333370-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTRICITY STORAGE DEVICE USING SAME UBE INDUSTRIES, LTD. (JP) 2015-11-19 US disclosed
US-20150221985-A1 NON-AQUEOUS ELECTROLYTE AND POWER STORAGE DEVICE USING SAME UBE INDUSTRIES, LTD. (JP) 2015-08-06 US disclosed
US-20150221985-A1 NON-AQUEOUS ELECTROLYTE AND POWER STORAGE DEVICE USING SAME UBE INDUSTRIES, LTD. (JP) 2015-08-06 US disclosed
US-20150221985-A1 NON-AQUEOUS ELECTROLYTE AND POWER STORAGE DEVICE USING SAME UBE INDUSTRIES, LTD. (JP) 2015-08-06 US disclosed
EP-2889947-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTRICITY STORAGE DEVICE USING SAME UBE Industries, Ltd. (JP) 2015-07-01 EP disclosed
EP-2882030-A1 NON-AQUEOUS ELECTROLYTE AND POWER STORAGE DEVICE USING SAME Ube Industries, Ltd. (JP) 2015-06-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200392142-A1 CDK2/4/6 Inhibitors CDK2, CDK6, CDK20 CYP3A4 1108/4885CYP2C9 1175/4885CYP2C19 1039/4885
US-11396512-B2 CDK2/4/6 inhibitors CDK2, CDK6, CDK20 CYP3A4 1137/4885CYP2C9 1172/4885CYP2C19 1040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.